Cargando…
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes. However, the application of this technique is restricted by the paucity of suitable tumor-associated antigens (TAAs) and the sop...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048802/ https://www.ncbi.nlm.nih.gov/pubmed/32111828 http://dx.doi.org/10.1038/s41467-020-14906-9 |